Fact check: Was remdesivir treatment associated with a 62% reduction in mortality rate?

Medical Sciences Asked by unutbu on August 29, 2021

On July 10, 2020, Gilead announced

remdesivir treatment was associated with significantly improved clinical
recovery and a 62 percent reduction in the risk of mortality compared to
standard of care…. The mortality rate for patients treated with remdesivir in
the analysis was 7.6 percent at Day 14 compared with 12.5 percent among patients
not taking remdesivir (adjusted odds ratio 0.38, 95% confidence interval
0.22-0.68, p=0.001).

How is the 62% reduction calculated? Naively, a drop from 12.5% to 7.6% appears to be a 39% (=(12.5-7.6)/12.5) reduction.

Add your own answers!

Related Questions

What does NKX2-5 do?

1  Asked on November 4, 2021


Why use a placebo in some potential COVID-19 vaccine trials?

4  Asked on August 29, 2021 by pymekrolimus


What happens when you put O+ blood in O- body

1  Asked on August 29, 2021 by frezzley


How does refeeding syndrome cause pitting edema?

1  Asked on August 29, 2021 by d-tan


Why transfused blood has lower 2,3 – BPG levels

1  Asked on August 29, 2021 by physicsapproval


Ask a Question

Get help from others!

© 2022 All rights reserved. Sites we Love: PCI Database, MenuIva, UKBizDB, Menu Kuliner, Sharing RPP, SolveDir